Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Lièvre

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Fundamental & Clinical Pharmacology|August 15, 2009
Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysisMichel Lièvre, Michel Cucherat
Contraception|June 9, 2009
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancyMichel Lièvre, Regine Sitruk-Ware
Current Controlled Trials in Cardiovascular Medicine|May 7, 2002
Pooling, meta-analysis, and the evaluation of drug safetyMichel Lièvre, Michel Cucherat, Alain Leizorovicz
Diabetes Care|May 30, 2006
Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) studyMichel Azizi, Joël Ménard, Séverine Peyrard, et al.
The American Journal of Geriatric Cardiology|July 31, 2003
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patientsEric Bruckert, Michel Lièvre, Philippe Giral, et al.
Trials|October 3, 2013
Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practiceDenis Pouchain, Michel Lièvre, Dominique Huas, et al.
Journal of Clinical Epidemiology|January 30, 2008
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linearJean-Pierre Boissel, Michel Cucherat, Patrice Nony, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2009
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRETThomas Philipp, Franck Martinez, Helmut Geiger, et al.
Heart (British Cardiac Society)|April 18, 2014
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple scoreBernard Iung, Cédric Laouénan, Dominique Himbert, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 3, 2015
Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry)Takahide Arai, Marie-Claude Morice, Stephen A O'Connor, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Fundamental & Clinical Pharmacology|August 15, 2009
Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysisMichel Lièvre, Michel Cucherat
Contraception|June 9, 2009
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancyMichel Lièvre, Regine Sitruk-Ware
Current Controlled Trials in Cardiovascular Medicine|May 7, 2002
Pooling, meta-analysis, and the evaluation of drug safetyMichel Lièvre, Michel Cucherat, Alain Leizorovicz
Diabetes Care|May 30, 2006
Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) studyMichel Azizi, Joël Ménard, Séverine Peyrard, et al.
The American Journal of Geriatric Cardiology|July 31, 2003
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patientsEric Bruckert, Michel Lièvre, Philippe Giral, et al.
Trials|October 3, 2013
Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practiceDenis Pouchain, Michel Lièvre, Dominique Huas, et al.
Journal of Clinical Epidemiology|January 30, 2008
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linearJean-Pierre Boissel, Michel Cucherat, Patrice Nony, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2009
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRETThomas Philipp, Franck Martinez, Helmut Geiger, et al.
Heart (British Cardiac Society)|April 18, 2014
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple scoreBernard Iung, Cédric Laouénan, Dominique Himbert, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 3, 2015
Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry)Takahide Arai, Marie-Claude Morice, Stephen A O'Connor, et al.
Pageof 2